What is Verantos?
Verantos stands as a market leader in the generation of high-accuracy, real-world evidence (RWE). The company's proprietary RWE platform is engineered to integrate diverse real-world data sources, producing evidence of a caliber suitable for regulatory submissions and reimbursement decisions. By harnessing advanced data science, artificial intelligence, and comprehensive data sources like electronic health records, Verantos generates RWE that can robustly support clinical assertions, positioning it at the forefront of data-driven healthcare innovation.
How much funding has Verantos raised?
Verantos has raised a total of $79K across 1 funding round:
Debt
$79K
Debt (2021): $79K with participation from PPP
Key Investors in Verantos
PPP
Public-Private Partnership
What's next for Verantos?
With the recent substantial expansion capital, Verantos is poised for significant scaling and market penetration. The company's strategic focus will likely involve enhancing its RWE platform capabilities, expanding its data integration partnerships, and broadening its client base across pharmaceutical, biotechnology, and healthcare sectors. This investment will fuel further research and development, enabling Verantos to solidify its leadership in providing critical evidence for clinical and commercial decision-making, thereby driving the adoption of RWE in healthcare.
See full Verantos company page
